Article

Vision science research at center of Jules Stein

Since its earliest days, the Jules Stein Eye Institute at the University of California-Los Angeles has been known as a center for vision science research, with the goal of preserving and restoring eyesight.

Los Angeles-Since its earliest days, the Jules Stein Eye Institute (JSEI) at the University of California–Los Angeles (UCLA) has been known as a center for vision science research, with the goal of preserving and restoring eyesight.

The result is a unique blend of compassionate patient care, innovative resident education, and profound research opportunities for motivated scientists.

Residents do clinical rotations at the UCLA Medical Center, plus two county hospitals and two Veteran's Administration (VA) hospitals-all told, an area about 60 miles at its widest points.

"At our county hospitals, we get a lot of acute ophthalmological problems, including trauma, whereas at the VA we get more chronic conditions: glaucoma, macular degeneration, and cataracts," Dr. Mondino said. "Plus, at UCLA itself, we get rare esoteric cases from all over the world. When you put it together, you get a broad cross section of cases. There's nothing they don't do."

Surgical training begins in the fall of the residents' first year, embracing an educational trend that has pushed that frontier earlier than before. At JSEI, first-year residents get a lot of didactic and wet lab experience, and attend a phacoemulsification course. In their second year, they begin picking up their own cases, and in their third year they receive "massive exposure" to surgery, Dr. Mondino said.

The training is augmented by a surgical simulator, acquired last year, which allows residents to practice virtual surgery.

"You sit down and, with your hands, you do the simulated surgery," he said. "It gives you the feeling and shows you what you're doing so you can practice phacoemulsification."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.